Cambridge Advisors’s Veradigm Inc. Common Stock MDRX Stock Holding History
Bought
Maintained
Sold
Other funds holding MDRX
Cambridge Advisors's MDRX Position: Q1 2022 in Review
Cambridge Advisors sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2022, closing a stake of 11,750 shares — an estimated $217K sold.
Cambridge Advisors first reported a position in MDRX in Q4 2014 and held it in 29 quarters. The position peaked at $225K in Q4 2015. 255 funds tracked by Wall St. Rank hold MDRX as of Q1 2022.
- Cambridge Advisors reported no remaining Veradigm Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
- Cambridge Advisors sold 11,750 Veradigm Inc. Common Stock shares in Q1 2022, an estimated $217K.
- Cambridge Advisors first reported a position in Veradigm Inc. Common Stock in Q4 2014 and held it in 29 quarters.
- Cambridge Advisors's Veradigm Inc. Common Stock position peaked at $225K in Q4 2015.
- 255 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2022.
Based on Cambridge Advisors's 13F filing for Q1 2022, filed 5 May 2022.